NEUROFILAMENT LIGHT CHAIN, AN EARLY BIOMARKER FOR POLYNEUROPATHY IN HEREDITARY ATTR AMYLOIDOSIS.

被引:0
|
作者
Brunger, A. F. [1 ]
Berends, M. [2 ]
Bijzet, J. [1 ]
Van der Zwaag, P. [3 ]
Kroesen, B. J. [4 ]
Teunissen, C. [5 ]
Veld, S. In T. [5 ]
Drost, G. [6 ]
Lange, F. [6 ]
Gans, R. [2 ]
Hazenberg, B. [1 ]
Nienhuison, H. L. A. [2 ]
机构
[1] Univ Med Ctr Groningen, Rheumatol Clin Immunol, Groningen, Netherlands
[2] Univ Med Ctr Groningen, Internal Med, Groningen, Netherlands
[3] Univ Med Ctr Groningen, Med Genet, Groningen, Netherlands
[4] Univ Med Ctr Groningen, Lab Med, Groningen, Netherlands
[5] Amsterdam UMC, Clin Chem, Locatie VUmc, Amsterdam, Netherlands
[6] Univ Med Ctr Groningen, Neurol, Groningen, Netherlands
关键词
D O I
10.1136/annrheumdis-2022-eular.4499
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
POS1395
引用
收藏
页码:1038 / 1038
页数:1
相关论文
共 50 条
  • [41] Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy
    Hayashi, Tomohiro
    Nukui, Takamasa
    Piao, Jin-Lan
    Sugimoto, Tomoyuki
    Anada, Ryoko
    Matsuda, Noriyuki
    Yamamoto, Mamoru
    Konishi, Hirofumi
    Dougu, Nobuhiro
    Nakatsuji, Yuji
    BRAIN AND BEHAVIOR, 2021, 11 (05):
  • [42] Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy
    van Lieverloo, Gwen
    Wieske, Luuk
    Verhamme, Camiel
    Michalak, Zuzanna
    Barro, Christian
    van Schaik, Ivo
    Kuhle, Jens
    Eftimov, Filip
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 277 - 277
  • [43] Neurofilament Light Chain (NfL) as a Potential Biomarker of Treatment Response in Hereditary Transthyretin-Mediated Amyloidosis: Data from the Patisiran Global OLE Study
    Polydefkis, Michael
    Ticau, Simina
    Erbe, David
    McManus, Anastasia
    Aldinc, Emre
    Adams, David
    Reilly, Mary M.
    Vaishnaw, Akshay
    Nioi, Paul
    NEUROLOGY, 2021, 96 (15)
  • [44] Tetraparesis and sensorimotor axonal polyneuropathy due to co-occurrence of Pompe disease and hereditary ATTR amyloidosis
    Zimmermann, Milan
    Deininger, Natalie
    Willikens, Sophia
    Haack, Tobias B.
    Grundmann-Hauser, Kathrin
    Streubel, Berthold
    Schreiber, Melanie
    Lerche, Holger
    Grimm, Alexander
    NEUROLOGICAL SCIENCES, 2021, 42 (04) : 1523 - 1525
  • [45] Tetraparesis and sensorimotor axonal polyneuropathy due to co-occurrence of Pompe disease and hereditary ATTR amyloidosis
    Milan Zimmermann
    Natalie Deininger
    Sophia Willikens
    Tobias B. Haack
    Kathrin Grundmann-Hauser
    Berthold Streubel
    Melanie Schreiber
    Holger Lerche
    Alexander Grimm
    Neurological Sciences, 2021, 42 : 1523 - 1525
  • [46] BURDEN OF ILLNESS FOR PATIENTS WITH HEREDITARY ATTR AMYLOIDOSIS WITH POLYNEUROPATHY BEGINS WITH SYMPTOM ONSET AND INCREASES WITH DISEASE PROGRESSION
    Denoncourt, R. N.
    Adams, D.
    Gonzalez-Duarte, A.
    O'Riordan, W.
    Yang, C.
    Yamashita, T.
    Kristen, A.
    Tournev, I
    Schmidt, H.
    Coelho, T.
    Berk, J.
    Lin, K.
    Chen, J.
    Gollob, J.
    Suhr, O.
    VALUE IN HEALTH, 2016, 19 (07) : A436 - A436
  • [47] Truncal sensory polyneuropathy in light-chain amyloidosis
    Clarke, Antonia J.
    Carroll, Antonia S.
    Bryant, Christian
    Halmagyi, Gabor M.
    PRACTICAL NEUROLOGY, 2023, 23 (02) : 166 - +
  • [48] MEASUREMENT PROPERTIES OF THE RASCH-BUILT OVERALL DISABILITY SCALE IN PATIENTS WITH HEREDITARY ATTR AMYLOIDOSIS WITH POLYNEUROPATHY
    Regnault, A.
    Denoncourt, R. N.
    Strahs, A.
    Agarwal, S.
    Marquis, P.
    Cano, S.
    VALUE IN HEALTH, 2017, 20 (05) : A330 - A330
  • [49] PULMONARY INVOLVEMENT IN SYSTEMIC LIGHT CHAIN (AL) AND TRANSTHYRETIN (ATTR) AMYLOIDOSIS
    Smith, E.
    Strachan, L.
    Gibbs, S.
    RESPIROLOGY, 2021, 26 : 20 - 20
  • [50] Neurofilament light chain as biomarker in idiopathic intracranial hypertension
    Beier, Dagmar
    Korsbaek, Johanne Juhl
    Madsen, Jonna Skov
    Olsen, Dorte Aalund
    Molander, Laleh Dehghani
    Hagen, Snorre M.
    Teunissen, Charlotte
    Beier, Christoph P.
    Jensen, Rigmor Hojland
    CEPHALALGIA, 2020, 40 (12) : 1346 - 1354